Intelligence Platform

Patents

Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8063195

Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058248

Foot and mouth disease virus vaccine comprising interferons

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8053422

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8053443

N-substituted indenoisoquinolines and syntheses thereof

granted patent

US 8048427

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044189

Bacillus anthracis protective antigen nucleic acid sequences

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044187

Human luteinizing hormone superagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039003

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039593

Antibodies and immunotoxins that target human glycoprotein NMB

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039585

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034334

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8029809

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030285

Oligodeoxynucleotide and its use to induce an immune response

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030280

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8022175

Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8017130

Method of accelerated vaccination against Ebola viruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8012730

Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008266

Methods of treating cancer using immunostimulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8008316

Azonafide derived tumor and cancer targeting compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003406

Methods for detecting attention-deficit/hyperactivity disorder

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003629

21-substituted progesterone derivatives as new antiprogestational agents

granted patent

US 8003112

Meningococcal and pneumococcal conjugate vaccine and method of using same

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999074

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7999071

Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted